Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 7—July 2020

Surveillance and Testing for Middle East Respiratory Syndrome Coronavirus, Saudi Arabia, March 2016–March 2019

Abdullah Alzahrani, Stephanie A. Kujawski, Glen R. AbediComments to Author , Safaa Tunkar, Holly M. Biggs, Nada Alghawi, Hani Jokhdar, Abdullah M. Assiri, and John T. Watson
Author affiliations: Ministry of Health, Riyadh, Saudi Arabia (A. Alzahrani, S. Tunkar, N. Alghawi, H. Jokhdar, A.M. Assiri); Centers for Disease Control and Prevention, Atlanta, GA, USA (S.A. Kujawski, G.R. Abedi, H.M. Biggs, J.T. Watson)

Main Article

Table 1

Case definitions for suspected MERS-CoV infection, Ministry of Health, Saudi Arabia, 2015 and 2018*

2015 case definition 2018 case definition
Acute respiratory illness with clinical and/or radiologic evidence of pulmonary parenchymal disease (pneumonia or ARDS)
Severe pneumonia (severity score >3 points) or ARDS (based on clinical or radiologic evidence)
A hospitalized patient with healthcare-associated pneumonia based on clinical or radiologic evidence
Unexplained deterioration of a chronic condition of patients with congestive heart failure or chronic kidney disease on hemodialysis
Upper or lower respiratory illness within 2 weeks after exposure to a confirmed or probable case of MERS-CoV infection
Acute febrile illness (temperature >38°C) with or without respiratory symptoms AND epidemiologic link†,‡
Unexplained acute febrile illness (temperature >38°C) AND body aches, headache, diarrhea, or nausea/vomiting, with or without respiratory symptoms, AND leucopenia (white blood cells <3.5 × 109/L) and thrombocytopenia (platelets <150 × 109/L)
Gastrointestinal symptoms (diarrhea or vomiting) AND leucopenia (white blood cells <3.5 × 109/L) or thrombocytopenia (platelets <150 × 109/L) AND epidemiologic link†,‡
unexplained severe pneumonia or meets >1 of the above case definition categories and in 14 days prior to symptom onset, has exposure to camels or camel products or to a confirmed or suspected MERS-CoV case-patient.

*Case definitions apply to adults only (>14 years of age) unless indicated. ARDS, acute respiratory distress syndrome; MERS-CoV, Middle East respiratory syndrome.
†Applies to children and adults.
‡Epidemiologic link defined as, within 14 days before symptom onset, exposure to a person with a confirmed case of MERS-CoV infection, visit to a healthcare facility where any MERS-CoV patient has been identified or treated within the preceding 2 weeks, or contact with dromedary camels or consumption of camel products.

Main Article

Page created: April 15, 2020
Page updated: June 18, 2020
Page reviewed: June 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.